The physical interaction between β-catenin and the adenomatous polyposis coli (APC) gene, and the ability of APC to regulate cytoplasmic levels of β-catenin suggest a role for β-catenin in colorectal carcinogenesis. In this study, we found that β-catenin immunoreactivity was detected exclusively in the cell membrane and cytoplasm of morphologically normal intestinal epithelial cells with predominant distribution in the differentiated nonproliferative cell population. In contrast, β-catenin was localized predominantly in the nucleus of adenomas from Min/ϩ mice and transgenic mice expressing a mutant truncated form of the APC gene (Apc ∆716 mice). β-catenin was expressed predominantly at the cell membrane and cytoplasm of the nontransformed rat intestinal epithelial (RIE-1) cells in culture, whereas predominantly nuclear localization of β-catenin was observed in the human colon cancer cell line SW480. In the azoxymethane (AOM) treated rats, overexpression and nuclear localization of β-catenin was observed in all adenomas. Previous studies have indicated the incidence of APC mutations amongst AOMinduced tumors to be 15% or less. These results demonstrate that nuclear localization of β-catenin is a common event in colorectal tumorigenesis.
Introduction
The genetic basis for colorectal neoplasia has become increasingly apparent over the past decade. The linkage of familial adenomatous polyposis (FAP*) to genetic markers on chromosome 5q21 (1, 2) led to the identification of the adenomatous polyposis coli (APC) gene, mutations of which cause FAP (3, 4) . Although germline mutations of APC associated with FAP accounts for Ͻ1% of all colorectal cancers, further studies revealed somatic mutations of APC occur in 60-85% of colorectal cancers and a similar majority of colorectal adenomatous polyps that are the precursor lesions for most colorectal cancers (5) (6) (7) (8) . The multiple intestinal neoplasia (Min) mouse serves as a murine model for FAP. These mice have a germline mutation in APC alleles resulting in numerous intestinal adenomas throughout the intestine (9) . Similar intestinal adenomas develop in APC knockout mice engineered with a truncation mutation in the APC gene (Apc ∆716 ) (10) . Tumor formation in Min/ϩ mice and Apc ∆716 knockout mice is similar to the human disease in that tumors form spontaneously in the absence of exogenous carcinogen. FAP patients, Min/ϩ, and Apc ∆716 mice inherit a defective APC allele from one parent and a wild-type allele from the other (reviewed by Kinzler and Vogelstein [11] ). Somatic mutation of the single wild-type allele appears to be rate-limiting for adenoma formation in both FAP patients and in mice with heterozygous APC truncations, whereas somatic mutations of both alleles occur in sporadic adenomas (8, 10, (12) (13) (14) . Interestingly, APC mutations have also been identified in 56% of colorectal cancers with the replication error (RER) phenotype, including tumors from patients with hereditary nonpolyposis colorectal cancer (HNPCC) (15) . While it is clear that APC mutation is an initiating factor in~85% of colorectal carcinomas (11) , the alterations in cellular regulation that occur because of this mutation have been less clearly understood. Further, there remains a small subgroup of primary colorectal cancers and colorectal adenocarcinoma cell lines (16) in which the APC protein product appears to be normal.
Greater than 95% of APC mutations in both FAP and sporadic colorectal cancers are C-terminal truncations (5, 6, 17) . Several proteins that interact with the C-terminus of the 2843 amino acid APC protein may prove to be important in colorectal neoplasia. These include the cadherin binding protein, β-catenin (18); a protein of unknown function, EB-1 (19) , and the human homolog of the Drosophila tumor suppressor gene discs large (DLG) (20) . There is mounting evidence that abnormalities in β-catenin regulation have an important role in neoplasia. β-catenin binds to APC through two motifs located in the central third of the APC protein, a region that is either absent or truncated in almost all tumor cells containing mutations in APC (11, 21, 22) . Wild-type APC binds to and dramatically reduces the levels of β-catenin by causing increased degradation of the β-catenin protein, whereas APC mutants lacking the central region lack this activity and are unable to downregulate β-catenin (23) . While β-catenin interacts with cadherins and is necessary for cadherin-mediated cell adhesion (reviewed in [24] [25] [26] ), recent evidence has strongly implicated β-catenin as a signal transducer in the WNT oncogene pathway. WNT1 promotes the accumulation of Fig. 1 . Histological analysis of Min /ϩ mouse and Apc ∆71 6 mouse adenomas and normal intestine. (A and B) β-catenin expression in normal small intestinal epithelium in Min /ϩ mouse (magnification ϫ400 and ϫ100); (C and D) β-catenin immunoreactivity in Min /ϩ adenoma (ϫ200 and ϫ400); (E and F) β-catenin expression in Apc ∆71 6 adenoma (ϫ100 and ϫ400); (G) Cyclin D1 immunoreactivity in Min /ϩ adenoma (ϫ400); (H) subcellular distribution of β-catenin in nontransformed RIE-1 cells (ϫ630) and (I) human colon cancer (SW-480) cells (ϫ630).
β-catenin in vertebrate cells (27, 28) and in Drosophila the expression of the WNT homolog, wingless (Wg), promotes the accumulation of armadillo, the β-catenin homolog (29) . Both Drosophila and vertebrate cells downregulate free cytosolic β-catenin levels through the constitutive activity of the homologous serine/threonine kinases zeste white 3 (zw3, Drosophila) and glycogen synthase kinase-3 (GSK3, vertebrates) (30) and the functions of these proteins are inhibited by activation of the WNT1 and Wg pathways, respectively. Destabilization of β-catenin by GSK-3 appears to involve phosphorylation of an amino terminal phosphorylation site in β-catenin (31). Stabilization of β-catenin by expression of a dominant negative mutant form of GSK-3 results in accumulation of the β-catenin in the cell nucleus (31) . Recent studies in Xenopus embryos and cultured mammalian cells have demonstrated that Wnt signalling involves binding of β-catenin with members of the Tcf/Lef family of high mobility group (HMG) transcription factors, co-translocation to the nucleus and regulation of selected genes with Tcf/Lef-1 promoter elements (32, 33) . Amino terminal truncated forms of β-catenin are transforming in NIH 3T3 fibroblast cells (34) , presumably due to the increased half-life of β-catenin mutants lacking critical phosphorylation sites near the amino-terminus (31) . Based upon the above observations, nuclear accumulation of β-544 catenin apparently is an important early event in intestinal carcinogenesis. Inomata et al. (35) reported the nuclear localization of β-catenin in colonic adenomas and carcinomas of FAP patients. In the present study, we compared the cellular distribution of β-catenin in morphologically normal intestine and in intestinal adenomas from Min/ϩ, APC null transgenic mice. We also examined the subcellular location of β-catenin in azoxymethane (AOM) induced adenomas in which APC mutations have been infrequently observed (36) . We found that morphologically normal intestinal epithelium exhibits the expected predominantly basolateral cell membrane β-catenin localization, with small amounts of cytoplasmic immunoreactivity, but no nuclear immunoreactivity. In contrast, nuclear localization of β-catenin is a common feature in intestinal adenomas from Min/ϩ, Apc ∆716 and from AOM-treated rats.
Materials and methods

Cell lines and animals
The human colon cancer cell line SW480, was purchased from American Type Culture Collection (Rockville, MD). The cells were maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum (FBS). A non-transformed rat intestinal epithelial cell line, RIE-1, was maintained as a monolayer in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS. Cytoplasm was separated by centrifugation at 550 g for 5 min. The nuclear pellets were washed twice with lysis buffer, and then lysed in RIPA buffer. Equal amount of cytoplasmic (C) and nucleus enriched (N) proteins were subjected to immunoblotting analysis for detection of β-catenin protein, Cdk4 or type I TGF-β receptor. (B) Determination of β-catenin-E-cadherin immunocomplex in RIE-1 and SW480 cells. Cells were lysed in NP-40 lysis buffer. 2 µg of anti-E-cadherin antibody was added into 250 µg of cell lysate. After incubation for 2 h at 4°C the immunocomplex (Compl. 1) was recovered with protein A-sepharose. The supernatants were subjected to the second precipitation with anti-E-cadherin antibody. Then, the supernatant and beads were separated by centrifugation, the beads were washed six times with lysis buffer, and eluted with SDS-PAGE sample buffer. The immunoprecipitates (Compl. 1 and Compl. 2) and supernatants (Sup.) from same amount of cell lysates were probed with anti-E-cadherin and anti-β-catenin antibodies.
Multiple intestinal neoplasia mice used for this study were (AKRϫB6) Apc Min /Apc ϩ mice produced by mating B6-Min Apc Min /Apc ϩ males with AKR females and referred to as Min/ϩ. The Apc ∆716 knockout mice have been previously characterized in detail (10, 37) . Specimens from the small intestine and colon were obtained by dissection under a dissecting microscope and fixed in either 4% paraformaldehyde (38) or 10% formaldehyde-PBS (10) as previously described.
The procotol for azoxymethane treatment has been described previously (39) . Briefly, male F344 rats at 7 weeks of age were administered AOM s.c. for 2 weeks (15 mg/kg wt once weekly). Colonic tumors and normal tissues were obtained after a 52-week period.
RNA extraction and Northern blot analysis
Total cellular RNA was extracted according to Chirgwin et al. (40) . RNA samples (20 µg per lane) were separated on formaldehyde-agarose gels and blotted onto nitrocellulose membranes. The blots were hybridized with cDNA probes labeled with [α-32 P]dCTP by random primer extension. After hybridization and washes, the blots were exposed to X-ray film for autoradiography. 18S rRNA signals were used as internal controls to determine the integrity of the RNA and the equality of loading among lanes.
Immunoblot analysis
Immunoblot analysis was done as previously described (41) . Briefly, the cells were lysed for 30 min in RIPA buffer (1ϫPBS, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml phenylmethyl-sulfonyl fluoride, 10 µg/ ml aprotinin, 100 mM sodium orthovanadate) then clarified cell lysates were denatured and fractionated by SDS-PAGE. After electrophoresis, the proteins were transferred to nitrocellulose membrane. The filters were then probed with the indicated antibodies, developed by ECL chemoluminescence system (Amersham, Arlington Heights, IL) and exposed to XAR5 film (Kodak, Rochester, NY). Quantitation was by video densitometry. The monoclonal anti-β-catenin antibody (against residues 571-781 of mouse β-catenin) was purchased from Transduction Laboratories (Lexington, KY). Anti-cdk 4 and anti-TGF-β type I receptor (TRI) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
For preparation of cytoplasmic and nuclear protein, cell membranes were lysed by lysis buffer (0.5% NP-40, 20 mM Tris-HCl pH 7.4, 10 mM NaCl, and 2 mM MgCl 2 ) for 2 min at 4°C. After centrifugation at 550 g for 5 min, supernatants were collected as cytoplasmic protein. 0.1% SDS, 25 µg/ml aprotinin and 25 µg/ml leupeptin were added into the lysates. Then, the nuclear pellets were washed by lysis buffer, and lysed by RIPA buffer. Immunoprecipitation For immunoprecipitation, cells were lysed in NP-40 lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF, 25 µg/ml leupeptin, 25 µg/ml aprotinin, 1 mM benzamidine, 10 µg/ml trypsin inhibitor, 10 mM β-glycerolphosphate). Two µg of monoclonal anti-E-cadherin antibody (against residues 735-883 of 545 human E-cadherin, Transduction Laboratories, Lexington, KY) was added into 250 µg of cell lysate. After incubation for 2 h at 4°C the antibodies were recovered with protein A-sepharose (Sigma, St Louis, MO). The supernatants were subjected to the second precipitation with anti-E-cadherin antibody. Then, the supernatant and beads were separated by centrifugation, the beads were washed six times with lysis buffer, and eluted with SDS-PAGE sample buffer. The immunoprecipitates and supernatants from the same amount of cell lysates were probed with anti-E-cadherin and anti-β-catenin antibodies.
Immunohistochemistry
Paraffin-embedded sections (5 µm) were prepared, deparaffinized and rehydrated in xylene, graded alcohol, and phosphate-buffered saline (PBS), respectively. The endogenous peroxidase activity was quenched by incubating the sections in 0.3% hydrogen peroxide for 20 min at room temperature. After the sections were blocked in 1.5% normal goat serum in PBS for 1 h, mouse monoclonal anti-β-catenin antibody (Transduction Laboratories, Lexington, KY) was applied on the sections and incubated overnight at 4°C. Then, the sections were incubated with biotinylated goat anti-mouse antibody and ABC-AP reagent according to the manufacturer's instruction (Vectorstain ABC-AP kit, Vector Laboratories, Burlingame CA). Peroxidase activity was shown by applying 3,3Ј-diaminobenzidine tetrahydrochloride containing 0.02% of hydrogen peroxide for 10 min. The sections were counterstained with toluidine blue O and mounted with coverslips. The sections from same blocks without adding anti-β-catenin antibody served as negative controls. The detection of cyclin D1 immunoreactivity served as a positive control for nuclear staining. For immunocytostaining, 2ϫ10 4 of RIE-1 and SW480 cells were seeded in separate chambers on the same 4-well chamber slides, incubated for 2 days, and subjected to simultaneous immunostaining.
Results
Distribution of β-catenin in hereditary intestinal tumorigenesis
The catenins were originally identified as cytoplasmic proteins that bind to cadherins, a family of calcium-dependent homophilic cell adhesion molecules. The cell surface protein Ecadherin linked to the cytoskeleton by α-and β-catenins mediates cell-cell adhesion in epithelial cells. Reduced cellcell adhesion is thought to enhance the ability to invade and metastasize in colonic neoplasia. On the other hand, β-catenin is also involved in the Wg/WNT signaling pathway. β-catenin binds to the Tcf/Lef family of HMG box transcription factors and directly regulates transcriptional activity. Therefore, differential distribution of β-catenin would imply different functions. Stabilization and overexpression of β-catenin result in nuclear accumulation (32, 33) and cell transformation in cultured cell systems (34) . Therefore, it is important to determine whether there is subcellular redistribution of β-catenin in intestinal neoplasia.
Representative tissue sections from adenomatous lesions and normal epithelium from the same animals were examined for β-catenin immunoreactivity. Immunohistochemical analyses revealed that β-catenin was clearly detectable along the basolateral membrane and in the cytoplasm of morphologically normal intestinal epithelial cells in Min/ϩ mouse ( Figure 1A) . The abundance of β-catenin immunoreactivity was less in the crypts and was increased toward the villus tips in the lumenal 1/2 to 2/3 of the normal small intestinal epithelium ( Figure  1B) . A similar distribution of β-catenin was observed in the normal mouse colon with increased expression near the lumenal portion of the colonic gland and the histologically normal colonic epithelium exhibited predominantly basolateral cell membrane distribution (not shown). This distribution of β-catenin in the normal mouse intestine is consistent with the recent findings of Nathke et al. (42) . In Min/ϩ mouse ( Figure  1C and D) and Apc ∆716 mouse ( Figure 1E and F) adenomas, β-catenin was predominantly localized to nuclei of the dysplastic intestinal epithelium with less immunoreactivity detectable along the cell membrane or in the cytoplasm. The adenomas from the Apc ∆716 mice examined in this study were at different phases of tumor progression. Nuclear translocation of β-catenin was observed in most tumors, including early adenomas that are characterized by their small size ( Figure 1E ) and low grade 546 of dysplasia. Most of the Min/ϩ mouse and Apc ∆716 mouse adenomas were found in the small intestine; however, colonic adenomas also exhibited identical β-catenin nuclear localization (data not shown). For comparison, we show similar nuclear localization of cyclin D1 in a Min/ϩ mouse intestinal adenoma ( Figure 1G ). We have recently reported this G1 cyclin to be abundant in the nuclei of Min/ϩ mouse intestinal adenomas, but not detectable in normal intestinal epithelium (38) .
Nuclear localization of β-catenin in intestinal epithelial cell cultures
We next examined the distribution of β-catenin in a nontransformed rat intestinal epithelial (RIE-1) cell line that expresses a full-length APC protein (our unpublished results), and in a human colon cancer cell line (SW480) known to express a mutant truncated form of the APC protein (43, 44) . Immunostaining of the RIE-1 and SW480 cells in culture revealed that β-catenin immunoreactivity was predominantly localized in the cytoplasm of the nontransformed RIE-1 cells ( Figure 1H ) and β-catenin was predominantly found in the nuclei of the SW480 cells ( Figure 1I) .
In order to further characterize the distribution of β-catenin protein in the intestinal cell lines, cytoplasmic and nuclear proteins were separately extracted from the RIE-1 and SW480 cells. The levels of β-catenin protein were determined by immunoblotting of equivalent amounts of protein from cytoplasm and nucleus. β-catenin was clearly more abundant in cytoplasm-enriched as compared to the nucleus-enriched protein extract from RIE cells (Figure 2A ). In contrast, β-catenin was more abundant in the nucleus-enriched extract of the SW480 colon cancer cells as compared to cytoplasm-enriched extract. Blots of these extracts were also developed with antibodies to either Cdk4 (a nuclear protein), or type I TGF-β receptor (TRI, a cell membrane receptor), as controls to demonstrate the relative enrichment for nuclear or cytoplasmic proteins. Cdk4 immunoreactivity was detected only in the nucleus-enriched extract, whereas TRI was predominantly detected in the cytoplasm-enriched fraction in the RIE cells and exclusively in the cytoplasm-enriched fraction from the SW480 cells. As demonstrated in Figure 2B , the amount of free intracellular β-catenin in the RIE-1 and SW480 cell lines was next evaluated in coprecipitation experiments. When lysates from these cells were subjected to immunoprecipitation with an antibody to E-cadherin, virtually all of the E-cadherin was detectable in the precipitate ( Figure 2B Compl. 1) by subsequent immunoblotting with E-cadherin antibody. In contrast, almost no remaining E-cadherin was detectable in immunoblots of the secondary immunocomplex and supernatants from the immunoprecipitation ( Figure 2B Compl. 2, Sup. ). In the RIE-1 cells, most of the detectable β-catenin was found in the E-cadherin complex, whereas abundant β-catenin was detectable in supernatants from the SW480 cell immunoprecipitates, and therefore not complexed with E-cadherin. Thus, in the nontransformed RIE-1 cells β-catenin is distributed predominantly along the cell membrane and found in the cytoplasmic fraction binding to E-cadherin, whereas in the SW480 cells, β-catenin is localized predominantly in the nucleus.
Expression and localization of β-catenin in AOM-induced adenomas
Since the overall abundance of β-catenin may determine the interaction with HMG transcription factors and nuclear accumulation, we examined the level of β-catenin mRNA and protein expression in neoplastic and normal colonic mucosal samples from AOM-treated rats. RNA blots were prepared from three pairs of normal colonic mucosa and colonic adenomas, and probed with β-catenin cDNA probe. As demonstrated in Figure 3A , β-catenin mRNA levels were elevated 5.1-, 3.2-, and 1.7-fold in adenomas as compared to the levels in the paired normal mucosa. The immunoblot analysis revealed that β-catenin protein in pooled histologically normal colonic mucosa was below the limit of detection; however, abundant β-catenin protein was detected in AOM-induced adenomas ( Figure 3B) .
Most of the Min/ϩ mouse and Apc ∆716 mouse adenomas are found in the small intestine. In contrast, AOM is a carcinogen that reproducibly causes predominantly colonic adenomas that progress to severe dysplasia and invasive carcinoma in rats and mice (45, 46) although the exact genetic targets, mutations of which lead to tumors, have yet to be defined. In AOM-treated rats, β-catenin immunoreactivity was detected at relatively low abundance and localized exclusively in the cytoplasm of histologically normal colonic mucosa near the surface epithelium, with little immunoreactivity in the colonic crypt ( Figure 4A ). In contrast, we observed abundant nuclear localization of β-catenin immunoreactivity in hyperplastic and dysplastic epithelium in eight out of eight AOMinduced adenomas ( Figure 4B and C).
Discussion
The significance of β-catenin as an oncogene has recently been emphasized. Korinek et al. (47) reported that β-cateninhTcf-4 complex constitutively displays transcriptional activity in APC-/-colon carcinoma cells. Reintroduction of APC removed β-catenin from hTCF-4 and abrogated the transcriptional transactivity. Rubinfeld et al. (48) recently showed that a genetic defect of APC causes posttranslational stabilization of β-catenin in melanoma cell lines. Ectopic expression of wild-type APC eliminated the excess β-catenin. Morin et al. (49) demonstrated that activation of β-catenin-Tcf signaling in colon cancer may also be caused by mutations in β-catenin that altered functionally significant phosphorylation sites. Human colon cancer cell lines HCT116 and SW48, which express wild type APC protein displayed constitutively active β-catenin-Tcf-regulated transcription. Mutations of β-catenin gene have been identified in these cells which lead to loss of serines (33 and/or 45) that have been implicated in the β-catenin turnover through phosphorylation by the GSK-3 β-kinase in Xenopus embryos (49) . Similar findings have also 547 been observed in melanoma cell lines where mutations of β-catenin result in stabilization of β-catenin protein and a constitutively active β-catenin-Lef-1 complex (48). Our results demonstrate that localization of β-catenin to the nucleus occurs in early intestinal adenomas that arise as the result of a APC gene mutation in Min/ϩ and Apc ∆716 models. Consistent with the findings of Inomata et al. (35) , we have observed abundant nuclear β-catenin immunoreactivity in multiple epithelial cells within the adenomas from FAP patients similar to that observed in the adenomas from the APC mutant mice (data not shown). Together, these results suggest that stabilization and nuclear translocation of β-catenin caused by APC truncation may be involved early in the intestinal carcinogenesis process in these animal models and in humans with hereditary or acquired loss of functional APC.
We also found overexpression of β-catenin at both mRNA and protein levels in azoxymethane-induced rat colonic adenomas. β-catenin was also localized in the nucleus of adenomas in this rodent model, in which most tumors have been shown to have intact APC (36) . Caderni et al. (36) analyzed 20 adenomas and 15 adenocarcinomas from AOM-treated rat colon. They found three APC mutations in two AOM-induced adenomas (15%) and 1 mutation in 15 adenocarcinomas (6%) suggesting that APC gene is not the common target of azoxymethane. Increased expression of β-catenin protein and nuclear localization in the AOM-induced tumors is correlated with increased levels of β-catenin mRNA. These data suggest that in addition to altered protein stability, which is known to occur when serines 33 and/or 45 are mutated (48, 49) , carcinogen exposure may also result in either increased β-catenin transcription or stabilization of the β-catenin mRNA. Overexpression and/or stabilization of β-catenin are likely responsible for the nuclear localization of β-catenin in this rodent model. Identifying whether AOM-induced colonic adenoma and adenocarcinoma express a mutant form of β-catenin mutations is a key issue for further investigation.
Taken together, the present findings suggest that β-catenin is predominantly expressed along the basolateral cell membrane and in cytoplasm of normal intestinal epithelial cells, consistent with its probable involvement in cell adhesion and cell migration. In the neoplastic epithelium, β-catenin is translocated into the nucleus implying that alterations in signal transduction by β-catenin may be important in intestinal tumor promotion. What would be the early functional consequences of this alteration in β-catenin regulation? The complete answer is not known, but recent studies have suggested several potential targets of regulation. We have recently reported that Min/ϩ mouse intestinal adenoma cells have a high proliferative index and express increased levels of Cdk4 and cyclin D1 (38) and decreased levels of type II TGF-β receptor (50) . The combined increase in expression of Cdk4 and cyclin D1 and decrease in expression of type II TGF-β receptor would likely maintain the intestinal adenoma cells in a proliferative state. Expression of these factors is abnormally regulated in intestinal adenomas as compared to morphologically normal intestinal epithelium. It may be that altered transcriptional activity resulting from deregulated β-catenin nuclear translocation is responsible for the expression of these tumor-promoting cell growth regulators. Studies are currently underway to address these important questions.
